Ingalls & Snyder LLC Sells 7,275 Shares of Haleon plc (NYSE:HLN)

Ingalls & Snyder LLC reduced its holdings in shares of Haleon plc (NYSE:HLN) by 16.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 36,635 shares of the company’s stock after selling 7,275 shares during the quarter. Ingalls & Snyder LLC’s holdings in Haleon were worth $302,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in HLN. FMR LLC boosted its stake in shares of Haleon by 22.2% during the 3rd quarter. FMR LLC now owns 53,951,936 shares of the company’s stock worth $449,420,000 after acquiring an additional 9,812,040 shares during the period. State Street Corp bought a new stake in Haleon in the 3rd quarter valued at $50,724,000. Alliancebernstein L.P. bought a new stake in Haleon in the 4th quarter valued at $48,960,000. Wellington Management Group LLP bought a new stake in Haleon in the 3rd quarter valued at $42,640,000. Finally, Sculptor Capital LP boosted its stake in Haleon by 184.7% in the 1st quarter. Sculptor Capital LP now owns 5,842,838 shares of the company’s stock valued at $47,561,000 after purchasing an additional 3,790,310 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Argus restated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th.

Haleon Stock Performance

HLN opened at $8.01 on Monday. The business has a fifty day simple moving average of $8.32 and a 200 day simple moving average of $8.30. The company has a market capitalization of $36.57 billion, a PE ratio of 28.61, a price-to-earnings-growth ratio of 2.10 and a beta of 0.29. Haleon plc has a 1 year low of $7.70 and a 1 year high of $9.05. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73.

Haleon Dividend Announcement

The company also recently declared a semi-annual dividend, which will be paid on Thursday, May 16th. Investors of record on Friday, March 15th will be paid a $0.1064 dividend. The ex-dividend date is Thursday, March 14th. This represents a yield of 1.8%. Haleon’s dividend payout ratio (DPR) is presently 75.00%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.